Articles by Leo Sun

Leo SunLeo Sun

is a freelance finance writer and position trader. He focuses on a combination of value and momentum investing, with a strong interest in the trading philosophies of Warren Buffett and Peter Lynch. Leo also has experience writing articles to help small business owners acquire loans and manage their finances. He regularly contributes to the Stock of the Day analysis.

Facebook (FB) Goes On a Wild Ride Following Robust Third Quarter Earnings

November 8th, 2013

Shares of Facebook (FB) went on a roller coaster ride last week, after the social networking giant reported its third quarter earnings. Facebook reported adjusted earnings of $0.25 per share, or $621 million, double the $0.12 per share, or $311 million, it earned in the prior year quarter. Revenue climbed 60% year-over-year to $2.02 billion. … READ MORE

Weight Watchers (WTW) Goes On A Crash Diet After Suspending Its Dividend

November 7th, 2013

Shares of Weight Watchers International (WTW) plunged more than 20% last week, after the company suspended its dividend in the latest sign of weakness for the troubled company. Over the past year, Weight Watchers has faced intensifying competition from free smartphone fitness and calorie tracking apps, as well as hybrid â

The Sun Shines Again On First Solar (FSLR)

November 5th, 2013

Shares of First Solar (FSLR) lit the markets on fire last week, after reporting blowout third quarter earnings. The stock was actually halted last Friday prior to its earnings announcement, when it reported adjusted earnings of $1.94 per share — completely smashing the consensus estimate of $1.13 per share. Revenue soared 50% year-over-year to $1.3 … READ MORE

Starbucks (SBUX) Is Still Sitting Pretty At All-Time Highs

November 4th, 2013

Coffee giant Starbucks (SBUX) impressed Wall Street again last week with robust fourth quarter earnings. The company earned an adjusted $0.63 per share, a 37% increase over the prior year quarter. Revenue climbed 13% to $3.8 billion, driven by new store openings, strong same-store sales in the United States, and increased traffic in Europe. Global … READ MORE

McKesson (MCK) Acquires $8.3 Billion Stake in Celesio

November 1st, 2013

Shares of healthcare services firm McKesson Corporation (MCK) surged last week, after the company reported that it would acquire a controlling stake in Celesio, a German healthcare and pharmaceutical company which operates in 14 countries across the world. Celesio employs approximately 38,000 employees and generated 22 billion euros ($30.3 billion) in revenue last year. Daily … READ MORE

Symantec (SYMC) Slides After Poor Second Quarter Earnings

October 31st, 2013

Antivirus software maker Symantec (SYMC) slid last week, after the company reported its second quarter earnings for fiscal 2014. The company reported adjusted earnings of $0.47 per share, a 16.7% year-over-year gain which easily topped the consensus estimate of $0.40. Revenue, however, declined 3.7% to $1.64 billion and missed the analyst forecast of $1.68 billion. … READ MORE

Big Shakeups Ahead For Boston Scientific (BSX)

October 29th, 2013

Medical equipment giant Boston Scientific (BSX) surprised investors last week, announcing that it would lay off up to 1,500 employees by the end of 2015, and that its long-time CFO Jeff Capello would resign at the end of the year. This all came after the company reported third quarter earnings which topped analyst estimates. What … READ MORE

Is Varian Medical Systems (VAR) Up or Down After Q4 Earnings Report?

October 28th, 2013

Shares of Varian Medical Systems (VAR) plunged last week, after the software and medical device maker reported lackluster fourth quarter earnings. The companyâ s earnings per share were flat from the prior year quarter at $1.08, although profit fell from $120.2 to $117.3 million, due to an increase in outstanding shares. Revenue rose 1.8% to … READ MORE

General Electric’s (GE) Third Quarter Earnings Light Up Its Stock

October 25th, 2013

Shares of diversified industrial conglomerate General Electric (GE) rallied recently, after the company reported its third quarter earnings. GE reported adjusted earnings of $0.36 per share, topping analyst expectations by a penny. Revenue rose 1.5% to $35.7 billion, which fell short of the $36.0 billion that analysts had expected. Daily Chart However, what caught investorsâ … READ MORE

Chipotle (CMG) Surges Even Higher On Strong Third Quarter Earnings

October 24th, 2013

Shares of Chipotle (CMG), one of the highest-flying growth stocks in the restaurant industry, surged even higher recently after the company reported mixed third quarter earnings. Chipotleâ s earnings per share rose 17.2% to $2.66, missing the consensus estimate of $2.78. However, revenue climbed 18% to $826.9 million, topping the $820.3 million which analysts had … READ MORE

Athenahealth (ATHN) Surges 20% Despite Missing Top and Bottom Line Estimates

October 22nd, 2013

Shares of Athenahealth (ATHN) surged last week, although the company reported earnings and revenue which both missed analyst estimates. For its third quarter, the company earned $0.03 per share, or $1.2 million, down sharply from the $0.17 per share, or $6.2 million, it reported in the prior year quarter. Excluding one-time items, especially its acquisition … READ MORE

Google (GOOG) Hits $1,000 For The First Time in History

October 21st, 2013

Shares of Google (GOOG) made history last week, with shares surging above $1,000 for the first time ever after the company posted third quarter earnings that comfortably surpassed analyst estimates. The company reported adjusted earnings of $10.74 per share on revenue of $14.89 billion. Analysts had expected the company to earn $10.34 per share on … READ MORE

Ariad (ARIA) Gets Crushed After Its Only Approved Treatment Is Put On Hold

October 18th, 2013

Shares of Ariad Pharmaceuticals (ARIA) crashed more than 70% last week, after the company reported that its top drug candidate, the leukemia drug Iclusig, had been put on a temporary hold by the FDA. The company announced that a number of patients given the drug experienced blood clots and heart damage. Daily Chart Ariad stated … READ MORE

Alnylam Pharmaceuticals’ (ALNY) New Cholesterol Treatment Could Be A Next Generation Blockbuster

October 17th, 2013

Earlier this month, Alnylam Pharmaceuticals (ALNY) impressed investors with positive results from its phase 1 study of its experimental high cholesterol drug, ALN-PCS. The results showed that ALN-PCS reduced LDL (“bad”) cholesterol by an average of 40%. Although this is an early study, it shows potential of becoming a new, more effective treatment in a … READ MORE

Achillion Pharmaceuticals (ACHN) Gets Wiped Out After FDA Maintains Hold On Its Lead Drug

October 15th, 2013

Shares of Achillion Pharmaceuticals (ACHN) crashed 60% last week, after the company stated that the FDA maintained its clinical hold on its leading hepatitis C (HCV) drug, sovaprevir, which has been on hold for more than three months due to fears that it could cause liver damage. That news devastated shareholders, who had hoped that … READ MORE

Gilead Sciences (GILD) Rallies After Ending a Late-Stage Trial Ahead of Schedule

October 14th, 2013

Shares of Gilead Sciences (GILD) surged last week, after the company announced that it had ended a late-stage clinical trial of its cancer drug idelalisib earlier than anticipated because it was confident that the treatment was working. Idelalisib is a new treatment for chronic lymphocytic leukemia (CLL) and indolent (slow growing) non-Hodgkin lymphoma (iNHL). Daily … READ MORE

Microsoft (MSFT) Investors Revolt Against Chairman Bill Gates

October 11th, 2013

Microsoft (MSFT) shareholders recently started a revolt against chairman Bill Gates, who co-founded the company 38 years ago and is still widely regarded as the face of the company. Three of the top 20 investors in Microsoft, which together own 5% of the company, are pressuring the board to force Bill Gates to step down, … READ MORE

Amazon (AMZN) Faces Major Challenges in France

October 10th, 2013

E-commerce giant Amazon (AMZN) was hit last week in France, after French lawmakers aimed to protect local bookshops from online booksellers. The newly passed law, which still needs to clear the Senate, bars online booksellers from offering free delivery to customers, as well as capping discounts at a maximum of 5%. The law reflects other … READ MORE

Tesla (TSLA) Stock Bursts Into Flames

October 8th, 2013

Shares of electric automaker Tesla Motors (TSLA) tumbled last week, after video footage of a fire engulfing its top-selling Model S started to circulate on the Internet, raising safety concerns regarding its lithium ion battery packs. Despite the ne…

Bill Ackman Concedes Defeat On Herbalife (HLF)

October 7th, 2013

It’s been a rough year for hedge fund manager Bill Ackman. His decision to short Herbalife (HLF) blew up in his face after activist investor Carl Icahn took him down, and his bet on a J.C. Penney (JCP) turnaround met with similar failure. During tha…